EUVIMEDEUVIMED entdecken
Crossref

Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors

Zhenzhen Yang, Feng Xu iD, Guan Wang, Yan Ran, Jian Wang, Jiaxin Teng, Yanghong Lv, Zhelin Fang, Yutong Ye, Xinkai Ye, Yijing Zhou, Weiqiang Yang und 1 weitere

ChemMedChem · 2026-01 · 21 (2)

DOI: 10.1002/cmdc.202501008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 31.01.2026. Verfasst von Zhenzhen Yang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Pharmaceutical Research Institute, Taizhou Vocational & Technical College, No. 788, Xueyuan Road, Jiaojiang District, Taizhou, 318000, P. R.…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, Molecular Docking Simulation, Antineoplastic Agents, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Science and Technology Plan Project of Taizhou, General Research Projects of Taizhou Vocational and Technical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two series of [1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine derivatives have been synthesized and evaluated for their antitumor activities. These compounds exhibit potent antiproliferative activities against A549 and H460 cells and c‐Met kinase inhibitory activities. Five compounds are highly effective against A549 and H460 cells with IC 50 values in 2.97–16.50 μM (the mean ± SD value of three independent determinations). Molecular docking is further performed to study the inhibitor–c‐Met kinase interactions, and the results show that compound 3a is potently bound to the c‐Met kinase with three hydrogen bonds, one π‐‐‐π, and one CH‐‐‐π interactions. Based on the preliminary results, it is deduced that compound 3a with potent c‐Met kinase inhibitory activity may be a potential anticancer agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-metMolecular Docking SimulationAntineoplastic AgentsProtein Kinase InhibitorsTriazolesHumansStructure-Activity RelationshipCell ProliferationDrug Screening Assays, AntitumorCell Line, TumorMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

X‐ray diffractionantitumor activitiesdocking studytetrazinetriazole

Substanzen

Proto-Oncogene Proteins c-metAntineoplastic AgentsProtein Kinase InhibitorsTriazoles

Autor:innen und Institutionen

  • Chemical Pharmaceutical Research Institute, Taizhou Vocational & Technical College, No. 788, Xueyuan Road, Jiaojiang District, Taizhou, 318000, P. R. China.
  • Research Institute, Zhejiang Haizhou Pharmaceutical Co. Ltd., No. 19, Donghai Fifth Avenue, Linhai City, Taizhou, 318000, P. R. China.
  • Research Institute, Zhejiang Hongyuan Pharmaceutical Co. Ltd., No. 6, Donghai Fourth Avenue, Linhai City, Taizhou, 318000, P. R. China.

ORCID-Profile: Feng Xu

Förderung

  • Science and Technology Plan Project of Taizhou
  • General Research Projects of Taizhou Vocational and Technical College

Zitieren

APA

Yang, Z., Xu, F., Wang, G., Ran, Y., Wang, J., Teng, J., Lv, Y., Fang, Z., Ye, Y., Ye, X., Zhou, Y., Yang, W., & Yan, J. (2026). Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors. ChemMedChem, 21(2). https://doi.org/10.1002/cmdc.202501008

Vancouver

Yang Z, Xu F, Wang G, Ran Y, Wang J, Teng J, et al. Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors. ChemMedChem. 2026;21(2). doi:10.1002/cmdc.202501008

BibTeX
@article{Yang2026,
  author = {Yang, Zhenzhen and Xu, Feng and Wang, Guan and Ran, Yan and Wang, Jian and Teng, Jiaxin and Lv, Yanghong and Fang, Zhelin and Ye, Yutong and Ye, Xinkai and Zhou, Yijing and Yang, Weiqiang and Yan, Jianbo},
  title = {Synthesis, Activity Evaluation, and Molecular Docking of 3‐Quinolin(one)ly‐[1,2,4]triazolo[4,3‐ b ][1,2,4,5]tetrazine Derivatives as c‐Met Inhibitors},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {2},
  doi = {10.1002/cmdc.202501008}
}
Kostenlos starten →